The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial
Dina Kao, Karen Wong, Rose Franz, Kyla Cochrane, Keith Sherriff, Linda Chui, Colin Lloyd, Brandi Roach, Anthony D. Bai, Elaine O. Petrof, Emma Allen‐Vercoe
Topics & Concepts
ClostridioidesTolerabilityNauseaMedicineVomitingInternal medicineAdverse effectAntibioticsAbdominal painQuality of life (healthcare)GastroenterologySurgeryMicrobiologyBiologyNursingClostridium difficile and Clostridium perfringens researchGut microbiota and healthProbiotics and Fermented Foods